Home TScan Therapeutics

TScan Therapeutics

In operation
Seasoned Equity Offering
Developer of New Anti-Tumor Drugs

Basic Information

TScan Therapeutics Focuses on Developing Immuno-Oncology Therapies to Enhance the Effectiveness of New Treatments That Don't Work for Patients by Reducing Drug Side Effects. By Discovering New Cancer Targets, TScan Develops Safe and Effective T-Cell Therapies for Patients to Improve Their Lives.
TScan Therapeutics, Inc.
Massachusetts,United States of America
51~100 people
January 01, 2018
info@tscan.com